Connection
Chad Rusthoven to Cost-Benefit Analysis
This is a "connection" page, showing publications Chad Rusthoven has written about Cost-Benefit Analysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.024 |
|
|
|
-
Bansal P, Rusthoven C, Boumber Y, Gan GN. The role of local ablative therapy in oligometastatic non-small-cell lung cancer: hype or hope. Future Oncol. 2016 Dec; 12(23):2713-2727.
Score: 0.024